Aguirre GJ

Language: English
References: 19
Page: 19-21
PDF size: 37.55 Kb.

Text Extraction

Although the liver biopsy alone is of little use for diagnosis of chronic hepatitis C, it is the most precise method for estimating the activity and stage of this disease. Liver biopsies can also provide information that is useful for assessing responses to treatments, making prognoses, detecting lesions, and in some cases, defining the urgency of treatment.

REFERENCES

1. Poynard T, Marcellin P, Lee SS, et al. Randomized trial of interferon alfa 2B plus ribavirin for 48 weeks versus interferon alfa 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (HIT). Lancet 1998; 352: 1426-32.

2. Manns MP, Hutchinson JG, Gordon SC, et al. PEG-interferon alfa-2b in combination with ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C. Lancet 2001; 358: 958-65.

3. Poynard T, Ratziu V, Hutchinson JG, et al. Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. Hepatology 2003; 38: 75-85.

4. Yano M, Kumada H, Kage M, et al. The long-term pathological evolution of chronic hepatitis. Hepatology 1996; 23: 1334-40.

5. Fontana RJ, Lok ASF. Noninvasive monitoring of patients with chronic hepatitis C. Hepatology 2002; 36: S57-S64.

6. Perrillo RP. The role of the liver biopsy in hepatitis C. Hepatology 1997: 26: S57-S61.

7. Nutt A, Hassan HA, Lindsey J, et al. Liver biopsy in the evolution of patients with chronic hepatitis have repeatedly normal or near-normal aminotransferase levels. Am J Med 2000; 109: 52-64.

8. Saadwh S, Cammell G, Carey WD, et al. The role of the liver biopsy in chronic hepatitis C. Hepatology 2001; 33: 196-200.

9. Guido M, Rugge M. Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis 2004; 24: 89-97.

10. Piccinino F, Sagnelli E, Pasquale G, et al. Complications following percutaneous liver biopsy. A multicentric retrospective study on 68,276 biopsies. J Hepatol 1986; 2: 165-73.

11. Colloredo G, Guido M, Sonzogni A, et al. Impact of liver biopsy on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003; 39: 239-44.

12. Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-57.

13. Brunetti E, Silini E, Pistorio A, et al. Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis. J Hepatol 2004; 40: 501-6.

14. Brunt EM. Grading and staging histopathologic lesions of chronic hepatitis: the Knodell histologic index and beyond. Hepatology 2000; 31: 241-6.

15. Rousselet MC, Michalak S, Dupré F, et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005; 41: 257-64.

16. Bain VG, Bonacini M, Govindarajan S, et al. A multicentric study of the usefulness of liver biopsy in hepatitis C. J Viral Hepat 2004; 11: 375-82.

17. Andriulli A, Persico M, Iacobellis A, et al. Treatment of patients with HCV infection with or without liver biopsy. J Viral Hepat 2004; 11: 536-42.

18. The French Metavir Cooperativa Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15-20.

19. Colombo M Ninno ED, Franchis RD, et al. Ultrasound-assisted percutaneous liver biopsy: superiority of the Tru-Cut over the Menghini needle for diagnosis of cirrhosis. Gastroenterology 1988; 95: 487-9.